Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Duane Pinto

Interventional Cardiology Boston, MA Medical Doctor

NPI 1275521130 CMS profile 103230

1 Deaconess Rd, Palmer 415, Boston, MA 02215

Open in the dashboard

General payments

$490,648

488 records reported · program years 2019–2025

Research payments

$855

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,724,373 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Duane Pinto of Boston, MA is reported in the CMS Open Payments database as having received $490,648 across 488 general payments and $855 in research payments paid to them. Separately, studies naming them as principal investigator received $3,724,373 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $48,956 31
2024 General $44,579 54
2023 General $44,931 56
2022 General $101,939 85
2021 General $56,373 61
2020 General $86,559 53
2020 Research $300 1
2019 General $107,310 148
2019 Research $555 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Duane Pinto
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Duane Pinto were reported at $48,956. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Duane Pinto Interventional Cardiology median Middle half National median
2019 $107,310 $1,097 $329–$3,048 $163
2020 $86,559 $473 $161–$1,480 $114
2021 $56,373 $677 $233–$1,827 $132
2022 $101,939 $978 $333–$2,724 $149
2023 $44,931 $1,136 $382–$2,986 $160
2024 $44,579 $1,181 $395–$3,326 $164
2025 $48,956 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $224,887 228 payments
  2. Abiomed $108,886 80 payments
  3. Boston Scientific Corporation $33,687 31 payments
  4. Medtronic Vascular, Inc. $31,693 46 payments
  5. Medtronic, Inc. $21,090 29 payments
  6. Terumo Medical Corporation $17,843 28 payments
  7. Gilead Sciences, Inc. $14,205 7 payments
  8. Magenta Medical Inc $9,249 6 payments
  9. CSL Behring $7,800 4 payments
  10. Vascular Solutions, Inc. $6,000 1 payment
  11. Other $15,308 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $249,752 64 payments
  2. Honoraria $89,950 21 payments
  3. Travel and Lodging $68,818 139 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $54,613 21 payments
  5. Food and Beverage $20,856 237 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $5,450 4 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,200 1 payment
  8. Gift $10 1 payment
Products named General payments · program years 2019–2025
  1. Impella $108,886 80 payments
  2. OPTIS Vascular $79,401 98 payments
  3. OPTIS Structural Heart $48,956 31 payments
  4. Xience V coronary stent system $42,297 48 payments
  5. DRAGONFLY OPSTAR $32,162 8 payments
  6. Resolute $21,876 31 payments
  7. ADVISOR $12,122 2 payments
  8. General - Therapies $11,229 3 payments
  9. LOTUS EDGE $10,885 7 payments
  10. GENERAL - STRUCTURAL HEART $7,000 3 payments
  11. Other $75,717 167 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Novo Nordisk AS $555 4 payments
  2. Boston Scientific Corporation $300 1 payment

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$38,690

Medicare's payments for the services billed

Medicare patients

115

Average age 78

Services billed

228

47 women, 68 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 70%
Atrial fibrillation 57%
Arthritis 48%
Chronic kidney disease 47%
Diabetes 42%
Depression 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

493 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record